Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chondrolife is a topical combination cream-gel containing glucosamine hydrochloride, chondroitin sulfate, camphor, and menthol, developed for the treatment of osteoarthritis. It is designed to provide both chondroprotective and analgesic effects by modulating inflammation, regulating chondrocyte metabolism, and stimulating cartilage synthesis. Preclinical studies in rat models of carrageenan-induced acute gonarthritis have demonstrated that Chondrolife possesses significant antinociceptive activity, showing superior efficacy compared to chondroitin-only topicals and comparable early-phase efficacy to diclofenac-based gels. The formulation leverages the synergistic effects of cartilage matrix precursors and sensory modulators to address the pain and structural degradation associated with joint disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chondrolife.